-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Artivion, Lowers Price Target to $30

Benzinga·11/06/2026 19:48:54
Listen to the news
Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE:AORT) with a Buy and lowers the price target from $40 to $30.